HPV and Male Homosexuality in General Practice?

Papilloma Viral Infection Clinical Trial

— HPV  

Official title:

HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05078554
• Other study ID #: 8048
• Status: Completed
• Start date: May 27, 2021
• Est. completion date: January 27, 2022

Study information

• Verified date: October 2021
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: January 27, 2022
• Est. primary completion date: January 27, 2022
• Gender: Male
• Age group: 18 Years to 26 Years

Eligibility

Inclusion criteria:

• Age: 18-26 years
• Consultation at the HUS Cegidd as part of an STI screening
• Subject who expressed no opposition to participating in the study

Exclusion criteria:

• Refusal of the patient to participate in the study
• Subject who had already benefited from HPV vaccination (at least one dose)
• Inability to give informed consent
• Subject under safeguarde of justice
• Subject under guardianship or under curatorship

Related Conditions & MeSH terms

• Papilloma
• Papilloma Viral Infection
• Papillomavirus Infections
• Virus Diseases

Locations

Country	Name	City	State
France	Service du Trait d'Union - Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?		Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]